BR9803755A - Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas. - Google Patents

Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.

Info

Publication number
BR9803755A
BR9803755A BR9803755-2A BR9803755A BR9803755A BR 9803755 A BR9803755 A BR 9803755A BR 9803755 A BR9803755 A BR 9803755A BR 9803755 A BR9803755 A BR 9803755A
Authority
BR
Brazil
Prior art keywords
improved process
obtaining
correctly connected
insulin precursors
cystine bridges
Prior art date
Application number
BR9803755-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Franz-Josef Dr Rubroeder
Reinhold Dr Keller
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Priority to BRPI9816233A priority Critical patent/BRPI9816233B8/pt
Publication of BR9803755A publication Critical patent/BR9803755A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9803755-2A 1997-08-18 1998-08-17 Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas. BR9803755A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI9816233A BRPI9816233B8 (pt) 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
BR9803755A true BR9803755A (pt) 2000-03-28

Family

ID=7839275

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9803755-2A BR9803755A (pt) 1997-08-18 1998-08-17 Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.
BRPI9816233A BRPI9816233B8 (pt) 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI9816233A BRPI9816233B8 (pt) 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina

Country Status (20)

Country Link
US (3) US5986048A (cg-RX-API-DMAC7.html)
EP (2) EP0980874B1 (cg-RX-API-DMAC7.html)
JP (1) JP4291900B2 (cg-RX-API-DMAC7.html)
KR (2) KR100537842B1 (cg-RX-API-DMAC7.html)
CN (3) CN1483831B (cg-RX-API-DMAC7.html)
AR (1) AR016821A1 (cg-RX-API-DMAC7.html)
AT (2) ATE217012T1 (cg-RX-API-DMAC7.html)
AU (1) AU744824B2 (cg-RX-API-DMAC7.html)
BR (2) BR9803755A (cg-RX-API-DMAC7.html)
CA (1) CA2245151C (cg-RX-API-DMAC7.html)
CZ (1) CZ295679B6 (cg-RX-API-DMAC7.html)
DE (3) DE19735711C2 (cg-RX-API-DMAC7.html)
DK (2) DK0906918T3 (cg-RX-API-DMAC7.html)
ES (2) ES2177178T3 (cg-RX-API-DMAC7.html)
HU (2) HU228161B1 (cg-RX-API-DMAC7.html)
ID (1) ID20717A (cg-RX-API-DMAC7.html)
PL (1) PL191901B1 (cg-RX-API-DMAC7.html)
PT (2) PT980874E (cg-RX-API-DMAC7.html)
RU (2) RU2205836C2 (cg-RX-API-DMAC7.html)
TR (1) TR199801587A3 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
JP2003530316A (ja) * 1999-12-22 2003-10-14 ノボ ノルディスク アクティーゼルスカブ スクランブルした一本鎖ポリペプチドの抽出的再生法
US20030212248A1 (en) * 2000-07-12 2003-11-13 Furman Thomas Charles Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
MY143274A (en) 2005-12-22 2011-04-15 Genentech Inc Recombinant production of heparin binding proteins
CN101506222B (zh) 2006-07-14 2013-10-02 健泰科生物技术公司 重组蛋白的重折叠
EA018715B1 (ru) * 2007-07-03 2013-10-30 Эмджен Инк. Количественное определение белков с использованием сухого веса внутриклеточных телец
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
RU2524423C2 (ru) 2008-01-09 2014-07-27 Санофи-Авентис Дойчланд Гмбх Новые производные инсулина с чрезвычайно замедленным профилем время/действие
WO2009133529A2 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Processes for refolding of insulin
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
JP5832439B2 (ja) 2009-11-13 2015-12-16 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Glp−1アゴニスト、インスリン及びメチオニンを含む薬学的組成物
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
KR20140106452A (ko) * 2013-02-26 2014-09-03 한미약품 주식회사 신규한 인슐린 아날로그 및 이의 용도
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
WO2017040363A1 (en) 2015-09-02 2017-03-09 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
SG46612A1 (en) * 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
ATE350053T1 (de) * 1994-12-29 2007-01-15 Ferring Int Ct Sa Herstellung von humaninsulin
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
HU0600287D0 (en) 2006-05-29
CN1209437A (zh) 1999-03-03
PT906918E (pt) 2002-10-31
JP4291900B2 (ja) 2009-07-08
KR100574580B1 (ko) 2006-04-28
HU228161B1 (en) 2013-01-28
AU744824B2 (en) 2002-03-07
ES2176870T3 (es) 2002-12-01
PL191901B1 (pl) 2006-07-31
ES2177178T3 (es) 2002-12-01
KR100537842B1 (ko) 2006-03-23
TR199801587A2 (xx) 1999-03-22
ATE217012T1 (de) 2002-05-15
EP0980874B1 (de) 2002-05-02
JPH11130798A (ja) 1999-05-18
US6380355B1 (en) 2002-04-30
DE59803985D1 (de) 2002-06-06
AU8076398A (en) 1999-02-25
ATE217636T1 (de) 2002-06-15
KR20050067371A (ko) 2005-07-01
EP0980874A1 (de) 2000-02-23
US6727346B2 (en) 2004-04-27
EP0906918B1 (de) 2002-05-15
US5986048A (en) 1999-11-16
CN1483831A (zh) 2004-03-24
PT980874E (pt) 2002-10-31
HK1119449A1 (en) 2009-03-06
TR199801587A3 (tr) 1999-03-22
CZ295679B6 (cs) 2005-09-14
CN101186940A (zh) 2008-05-28
KR19990023651A (ko) 1999-03-25
BRPI9816233B8 (pt) 2021-05-25
EP0906918A3 (de) 1999-08-11
CN1483831B (zh) 2012-06-13
HUP9801886A2 (hu) 1999-01-28
RU2302882C2 (ru) 2007-07-20
PL328108A1 (en) 1999-03-01
HK1018464A1 (en) 1999-12-24
US20020156234A1 (en) 2002-10-24
CA2245151A1 (en) 1999-02-18
RU2205836C2 (ru) 2003-06-10
HK1061870A1 (en) 2004-10-08
HU9801886D0 (en) 1998-10-28
DE59804121D1 (de) 2002-06-20
CA2245151C (en) 2009-10-06
HUP9801886A3 (en) 1999-06-28
CN101186940B (zh) 2012-02-08
CN1132845C (zh) 2003-12-31
BRPI9816233B1 (pt) 2016-09-27
DK0906918T3 (da) 2002-09-09
EP0906918A2 (de) 1999-04-07
DE19735711C2 (de) 2001-04-26
HU228203B1 (en) 2013-01-28
CZ259898A3 (cs) 1999-03-17
AR016821A1 (es) 2001-08-01
ID20717A (id) 1999-02-18
DE19735711A1 (de) 1999-02-25
DK0980874T3 (da) 2002-08-19

Similar Documents

Publication Publication Date Title
BRPI9816233B8 (pt) processo de preparação de insulinas ou de um derivado de insulina
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
BR9814300A (pt) Método de preparação de óxidos de tetraidrobenzotiepina enanciomericamente enriquecidos
CY1109593T1 (el) Παραγωγα 12,13-κυκλοπροπανο εποθιλονης
DE59910083D1 (de) Verwendung von Thiazolidin- oder Pyrrolidinderivaten von Aminosäuren als antihyperglykämische Mittel
ATE254920T1 (de) Neue galenische zubereitungsformen von meloxicam zur oralen applikation
BR9905852A (pt) Poliuretanos termoplásticos alifáticos, processo para sua preparação e seu emprego
BR0115055A (pt) Terapia de combinação compreendendo agentes anticonvulsantes e antidiabéticos
ATE256658T1 (de) Funktionelle vitamin-d-derivate und verfahren zur bestimmung von 25-hydroxy- und 1alpha,25- dihydroxy-vitamin-d
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
EP1490483A4 (en) IN VIVO INSTALLATION OF NON-NATURAL AMINO ACIDS
BR9812501A (pt) Processo para a preparação de um pentopiranosilnucleosìdeo
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
ATE51437T1 (de) Verschluss fuer eine wickelbare muffe.
BR9909819A (pt) Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
BR9712100A (pt) Intermediários e processo para preparar olanzapina.
DK0987256T3 (da) Krystalform af N-(4-trifluormethylphenyl)-5-methylisoxazol-4-carboxylsyreamid
ATE408631T1 (de) Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion
BR9909260A (pt) Processo para o preparo de (r)-alfa-(2,3-dimetóxifenil)-1-[2-(4-fluoro-fenil)etil]-4-pi peridinametanol
BR0110206A (pt) Inibidores de peptìdeo deformilase
DK1342729T3 (da) Antistoffer og antisense-molekyler for G-koblet receptor der udviser selektiv affinitet for ATP
CY1105526T1 (el) Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης
BR9911224A (pt) Métodos para redução dos nìveis de homocisteìna e proteìna c-reativa
BR9809439A (pt) Processos para preparação de benzotiofenos
BR9810387A (pt) (s) 3, 4, 5-trimetoxibenzoato de 2-metilamino-2-fenil-n-butila, e sua aplicação para o tratamento de dor crÈnica

Legal Events

Date Code Title Description
TC Change of name
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA DE ACORDO COM O ART. 8O COMBINADO COM O ART. 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]